Biogen Inc. (IDP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 06:25PM CEST
| Previous close | 190.05 |
| Open | 189.10 |
| Bid | 195.85 x 10000 |
| Ask | 196.85 x 10000 |
| Day's range | 189.10 - 195.00 |
| 52-week range | 178.30 - 307.40 |
| Volume | |
| Avg. volume | 30 |
| Market cap | 28.391B |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 26.17 |
| EPS (TTM) | 7.45 |
| Earnings date | 23 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 413.19 |
Simply Wall St.Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
Simply Wall St.Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
ZacksSage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
© 2024 Yahoo. All rights reserved.